-
1
The real-world safety of Ofatumumab: a pharmacovigilance analysis based on the FDA adverse event reporting system
Published 2025-01-01Subjects: “…ofatumumab…”
Get full text
Article -
2
Subcutaneous immunotherapy in a patient taking ofatumumab for multiple sclerosis and upadacitinib for atopic dermatitis
Published 2025-05-01Subjects: Get full text
Article -
3
Real-world satisfaction and experience with injection and autoinjector device for ofatumumab indicated for multiple sclerosis
Published 2025-01-01Subjects: “…Ofatumumab…”
Get full text
Article -
4
Real-world pharmacovigilance of ofatumumab in multiple sclerosis: a comprehensive FAERS data analysis
Published 2025-01-01Subjects: “…ofatumumab…”
Get full text
Article -
5
The Role of the New Anti-CD20 Monoclonal Antibodies in Active Relapsing – Remitting Multiple Sclerosis Treatment: Efficacy and Safety of ofatumumab
Published 2024-03-01Subjects: Get full text
Article